Literature DB >> 24648305

Value of general surgical risk models for predicting postoperative morbidity and mortality in pancreatic resections for pancreatobiliary carcinomas.

Yoshio Haga1, Yasuo Wada, Toshihiro Saitoh, Hitoshi Takeuchi, Koji Ikejiri, Masakazu Ikenaga.   

Abstract

BACKGROUND: The present study evaluated the utility of general surgical risk models to predict postoperative morbidity and mortality in the specialty field of pancreatic resections for pancreatobiliary carcinomas.
METHODS: We investigated Estimation of Physiologic Ability and Surgical Stress (E-PASS), its modified version (mE-PASS), and Portsmouth Physiologic and Operative Severity Score for the enUmeration of Mortality and morbidity (P-POSSUM) in 231 patients undergoing pancreatoduodenectomy or distal pancreatectomy (Group A). We also analyzed E-PASS and mE-PASS in another cohort of the same procedures (Group B, n = 313).
RESULTS: Areas under the receiver operating characteristic curve (AUC) for detecting in-hospital mortality in Group A were moderate at 0.75 for E-PASS, 0.69 for mE-PASS, and 0.69 for P-POSSUM. The predicted mortality rates of the models significantly correlated with severity of postoperative complications (ρ = 0.17, P = 0.011 for E-PASS; ρ = 0.15, and P = 0.027 for P-POSSUM). The AUCs were also moderate in Group B at 0.68 for E-PASS and 0.69 for mE-PASS. The predicted mortality rates significantly correlated with severity of postoperative complications (ρ = 0.18, P = 0.0018 for E-PASS; ρ = 0.17, and P = 0.0022 for mE-PASS).
CONCLUSIONS: The present study suggests that the predictive powers of general risk models may be moderate in pancreatic resections. A novel model would be desirable for these procedures.
© 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Biliary carcinoma; mortality; pancreatic carcinoma; prediction; surgery

Mesh:

Year:  2014        PMID: 24648305     DOI: 10.1002/jhbp.105

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  6 in total

1.  Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.

Authors:  Minji Jang; Hyung Woo Park; Jimi Huh; Jong Hwa Lee; Yoong Ki Jeong; Yang Won Nah; Jisuk Park; Kyung Won Kim
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

2.  The EPOS-CC Score: An Integration of Independent, Tumor- and Patient-Associated Risk Factors to Predict 5-years Overall Survival Following Colorectal Cancer Surgery.

Authors:  Yoshio Haga; Koji Ikejiri; Yasuo Wada; Masakazu Ikenaga; Shoichiro Koike; Seiji Nakamura; Masato Koseki
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

3.  Is postoperative decrease of serum albumin an early predictor of complications after major abdominal surgery? A prospective cohort study in a European centre.

Authors:  Ismail Labgaa; Gaëtan-Romain Joliat; Amaniel Kefleyesus; Styliani Mantziari; Markus Schäfer; Nicolas Demartines; Martin Hübner
Journal:  BMJ Open       Date:  2017-04-08       Impact factor: 2.692

4.  The Role of Exercise in the Quality of Life in Patients After Pancreatectomy: A Prospective Randomized Controlled Trial.

Authors:  Anastasios Katsourakis; Ioannis Vrabas; Vassilios Papanikolaou; Stylianos Apostolidis; Iosif Chatzis; George Noussios
Journal:  J Clin Med Res       Date:  2018-12-03

Review 5.  The accuracy of pre-operative (P)-POSSUM scoring and cardiopulmonary exercise testing in predicting morbidity and mortality after pancreatic and liver surgery: A systematic review.

Authors:  J Dutton; M Zardab; V J F De Braal; D Hariharan; N MacDonald; S Hallworth; R Hutchins; S Bhattacharya; A Abraham; H M Kocher; V S Yip
Journal:  Ann Med Surg (Lond)       Date:  2020-12-28

6.  A simplified scoring system for the prediction of pancreatoduodenectomy's complications: An observational study.

Authors:  Long Chen; Dai-Wen Su; Fan Zhang; Jun-Yi Shen; Yan-Hong Zhang; Yun-Bing Wang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.